Patent details
EP2604257 Title: Oral transmucosal dosage forms comprising sufentanil and triazolam
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- EP2604257
- WO Application Number:
- Type:
- European Patent Granted for NL
- Status:
- Lapsed by non-payment of annual fee Art. 62 ROW
- Publication Title:
- Title When Made Available For Viewing:
- Reason Lapsed:
- Application number:
- EP13158781.8
- WO Publication Number:
- EPO Publication Language:
- English
- SPC Number:
- First Applicant Residence Country:
- United States of America (US)
- Publications:
Dates
- Filing date:
- 07/08/2008
- Grant date:
- 28/06/2017
- EP Publication Date:
- 19/06/2013
- WO Publication Date:
- Claims Translations Received Date:
- Claims Translation B1 Received Date:
- 24/07/2017
- Claims Translation B2 Received Date:
- Claims Translation B3 Received Date:
- Lapsed By Non Payment Annual Fee Date:
- 01/09/2023
- Renunciation Date:
- NullificationDate:
- Published:
- Due To Cession Date:
- Registration date:
- 28/06/2017
- EP B1 Publication Date:
- 28/06/2017
- EP B2 Publication Date:
- EP B3 Publication Date:
- Description Translation B1 Received Date:
- Description Translation B2 Received Date:
- Description Translation B3 Received Date:
- Expiration date:
- 06/08/2028
- Lapsed By Expiration Date:
- Revocation Date:
- Invalidity Date:
- Response To Novelty Search Report Received:
- Patent Granting Request:
- Lapsed date:
Applicant/holder
- From:
- 28/06/2017
- Name:
- Acelrx Pharmaceuticals, Inc.
- Address:
- 575 Chesapeake Drive, REDWOOD CITY, CA 94063, United States of America (US)
Domicile Holder
- Name:
- ir. C.W.A.M. Klavers
- From:
- 24/07/2017
- Address:
- Octrooibureau Klavers B.V. Postbus 1642, 1300 BP, Almere, Netherlands (NL)
- To:
Inventor
1
- Name:
- Palmer, Pamela
- Address:
- San Francisco, CA California 94127, United States of America (US)
2
- Name:
- Tzannis, Stelios
- Address:
- Newark, CA California 94560, United States of America (US)
3
- Name:
- Schreck, Thomas
- Address:
- Portola Valley, CA California 94028, United States of America (US)
Priority
- Priority Patent Number:
- 954501 P
- Priority Date:
- 07/08/2007
- Priority Country:
- United States of America (US)
Classification
- IPC or IDT classification:
- A61K 9/00; A61K 9/70; A61K 31/4535; A61K 31/5517; A61P 25/20;
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 14/24
- Publication date:
- 03/04/2024
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- EP3
- Journal edition number:
- 32/17
- Publication date:
- 09/08/2017
- Description:
- European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
3
- Bulletin Heading:
- EP2
- Journal edition number:
- 26/17
- Publication date:
- 28/06/2017
- Description:
- European patents granted for the Netherlands
European Patent Bulletin
1
- Issue number:
- 201731
- Publication date:
- 02/08/2017
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
2
- Issue number:
- 201726
- Publication date:
- 28/06/2017
- Description:
- Grant (B1)
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 24/08/2022
- Last Annual Fee Paid Number:
- 15
- Last Annual Fee Paid Amount:
- 900 Euro
- Payer:
- Maxval Group
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 02/08/2017 | Outgoing Correspondence | Letter no formal defects | 1 | /8/0/2/0/7/0800170208/docs/ep13158781.8_1_153864l271.pdf | ||
| 24/07/2017 | Incoming Correspondence Electronic | Accompanying letter incoming document | 2 | /8/0/2/0/7/0800170208/docs/ep13158781.8_0_incomingcorrespondenceelectronic20170724153846257.pdf | ||
| 24/07/2017 | Claims | First filed claims | 3 | /8/0/2/0/7/0800170208/docs/ep13158781.8_2_claims20170724153845537.pdf |